Skip to main content
SpringerLink
Log in

HPV-16/18 genotyping for cervical screening

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The analysis was funded by Roche Molecular Diagnostics.

  2. Addressing THE Need for Advanced HPV Diagnostics

Reference

  • Huh WK, et al. Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening. Applied Health Economics and Health Policy : 11 Nov 2014. Available from: URL: http://doi.org/10.1007/s40258-014-0135-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HPV-16/18 genotyping for cervical screening. PharmacoEcon Outcomes News 717, 24 (2014). https://doi.org/10.1007/s40274-014-1749-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1749-3

Search

Navigation